---
trial_id: 459
discovery_date: 2022-04-05 21:16:14.385865
date: 2022-04-05 21:16:14.385865
title: "Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis"
summary: |
  <p>EudraCT Number: 2018-004557-24<br />Sponsor Protocol Number: UKM17_0056<br />Sponsor Name: Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel <br />Start Date: 2019-07-29<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004557-24/DE">DE</a> (Temporarily Halted)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004557-24'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2018-004557-24<br />Sponsor Protocol Number: UKM17_0056<br />Sponsor Name: Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel <br />Start Date: 2019-07-29<br />Medical condition: Multiple Sclerosis<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004557-24/DE">DE</a> (Temporarily Halted)</p>